BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Precision Biologics Presents At GI ASCO Jan 2014: Promising Drug Continues To Show Encouraging Results In Pancreatic And Colorectal Cancer Patients


1/15/2014 10:45:50 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Precision Biologics is pleased to announce a continuation of encouraging clinical data from its ongoing Phase 1-2a study utilizing its novel monoclonal antibody NPC-1C. The data will be presented by the investigators from Duke University at the ASCO GI meeting on January 17, 2014 in SF, CA. We previously reported results at the 2013 ASCO annual meeting using the initial formulation of NPC-1C (NEO-101) in patients with advanced pancreatic and colorectal cancer, who progressed on standard therapies.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES